A PRINTABLE AGENDA IS AVAILABLE. Archive (Video and Slides) of selected previous year talks is available (last year’s agenda).
![](https://pci-site-assets.s3.amazonaws.com/Images/Website-Header-BRC-CDx-2020-2048x325.png)
Companion Diagnostics Forum 2020 AGENDA
10:00 AM
– 10:15 AM
Welcome
Oscar Puig, Ph.D.
Event Chair
Translational Medicine, Oncology Late Stage Development
Translational Medicine, Oncology Late Stage Development
Eli Lilly
Ronnye Schreiber
CEO
PlanetConnect
![](https://pci-site-assets.s3.amazonaws.com/Photos/Oscar_Puig.png)
![](https://pci-site-assets.s3.amazonaws.com/Photos/Ronnye_Schreiber.jpg)
10:15 AM
– 11:00 AM
Keynote
KEYNOTE: Companion Diagnostics: Current Landscape and Future
Directions
Steve Anderson, Ph.D.
Chief Scientific Officer
Covance
![](https://pci-site-assets.s3.amazonaws.com/Photos/Steve_Anderson.jpg)
11:00 AM
– 11:30 AM
BREAK and Meet your colleagues!
11:30 AM
– 12:30 PM
Track 1: Biomarkers for Neurological Disorders
New Frontiers in CNS Blood-based Biomarkers
Andreas Jeromin, Ph.D.
Chief Scientific Officer
Cohen Veterans Biosciences
![](https://pci-site-assets.s3.amazonaws.com/Photos/Andreas_Jeromin.jpg)
Biomarkers for patient selection and monitoring drug treatments in
ALS clinical trials
Robert Bowser, Ph.D.
Chief Scientific Officer
Barrow Neurological Institute
![](https://pci-site-assets.s3.amazonaws.com/Photos/Robert_Bowser.jpg)
12:30 PM
– 1:30 PM
LUNCH BREAK and Discussion Group
1:30 PM
– 3:00 PM
Track 2: Next Generation Biomarkers in Oncology
A Saliva-based ctDNA Diagnostic for Oral Cancer
Radhakrishna Bettadapura
Senior Director Business Development
Strand Life Science
![](https://pci-site-assets.s3.amazonaws.com/Photos/Radhakrishna_Bettadapura.jpg)
Representative sampling to address tumor heterogeneity
Nelson Alexander,Ph.D.
Research Leader
Roche Sequencing Solutions
![](https://pci-site-assets.s3.amazonaws.com/Photos/Nelson_Alexander.png)
NGS-based approach Microsatellite Instability detection using
tumor only sample
Wei Ding, Ph.D.
Head of Bioinformatics
Admera Health
Chief Scientific Officer
Admera Health, China
![](https://pci-site-assets.s3.amazonaws.com/Photos/Wei_Ding.jpg)
3:00 PM
See you tomorrow at 10:00 AM EST
10:00 AM
– 11:15 AM
Track 3: Technology and Platforms
Enabling the Expansive Interrogation of a Tumor & Its
Microenvironment from a Single Sample for Translational Research
and Precision Medicine
Christelle Johnson. Ph.D.
Senior Field Applications Scientist
Personalis
Dawn McHugh
Senior Director, Strategic Business Development
Personalis
![](https://pci-site-assets.s3.amazonaws.com/ExhibitorLogos/Personalis.png)
Signature Sponsor
![](https://events.planetconnect.com/wp-content/uploads/contacts/photos/Personalis/Christelle-Johnson.jpg)
![](https://pci-site-assets.s3.amazonaws.com/Photos/Dawn_McHugh.jpg)
Strategies for biomarker screening, identification, and validation
in early stage translational research projects into clinical
application
Jacques Corriveau
President & CEO
Ultivue
![](https://pci-site-assets.s3.amazonaws.com/Photos/Jacques_Corriveau.png)
11:15 AM
– 12:15 PM
Track 4: Companion Diagnostics Development
Considerations for Development and Implementation of a CDx
Karen Richards, RAC
Senior Vice President, In Vitro Diagnostics and Quality
Precision for Medicine
![](https://pci-site-assets.s3.amazonaws.com/Photos/Karen_Richards.jpg)
Key Considerations for Late-Stage Diagnostic Development
Lloye Dillon, Ph.D.
Associate Director, Pharmacodiagnostics
Bristol-Myers Squibb
![](https://pci-site-assets.s3.amazonaws.com/Photos/Lloye_Dillon.jpg)
12:15 PM
– 1:00 PM
LUNCH BREAK and Discussion Group
1:00 PM
– 2:00 PM
Track 5: Pain Points and Barriers to Innovation
The evolving landscape of oncology clinical trials: clinician
perspectives on drivers and barriers to pharmaceutical innovation
Colin Enderlein
Project Leader
DeciBio
![](https://pci-site-assets.s3.amazonaws.com/Photos/Colin_Enderlein.jpg)
Update on the adoption and utilization of emerging precision
medicine tools and technologies in routine clinical care
Andrew Aijian, Ph.D.
Partner
DeciBio
![](https://pci-site-assets.s3.amazonaws.com/Photos/Andrew_Aijian.jpg)
2:00 PM
– 2:30 PM
Meet the Speaker – Discussion Group
3:00 PM
Thank you for coming!